2,454 followers
DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation. #lymphoma #lymsm https://t.co/bqUChDmcan
DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation. #lymphoma #lymsm https://t.co/bqUChDmcan
New article: DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation. https://t.co/zaAyaXPnMh #DLBCL #lymsm #hematology https://t.co/JYTAz90SBD